Fengwen Li

614 total citations
20 papers, 377 citations indexed

About

Fengwen Li is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Fengwen Li has authored 20 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Physiology and 5 papers in Cancer Research. Recurrent topics in Fengwen Li's work include Natural product bioactivities and synthesis (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and NF-κB Signaling Pathways (4 papers). Fengwen Li is often cited by papers focused on Natural product bioactivities and synthesis (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and NF-κB Signaling Pathways (4 papers). Fengwen Li collaborates with scholars based in China, United States and Sri Lanka. Fengwen Li's co-authors include Yunman Li, Weirong Fang, Lifang Liu, Congrong Wang, Yinan Zhang, Peng Cheng, Ying Xiong, Hua Chen, Zhenzhen Liu and Qi-Gui Bo and has published in prestigious journals such as Journal of Ethnopharmacology, Journal of Affective Disorders and Brain Behavior and Immunity.

In The Last Decade

Fengwen Li

19 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengwen Li China 12 143 61 60 52 44 20 377
Li‐Quan Hu China 10 136 1.0× 140 2.3× 43 0.7× 25 0.5× 20 0.5× 32 585
Yu Mi Park South Korea 14 182 1.3× 9 0.1× 24 0.4× 30 0.6× 25 0.6× 30 466
Anna Nakamura Japan 12 121 0.8× 22 0.4× 60 1.0× 19 0.4× 7 0.2× 21 360
Jeong‐Eun Yoo South Korea 11 251 1.8× 36 0.6× 6 0.1× 37 0.7× 14 0.3× 64 512
Xueqin Zhang China 13 160 1.1× 36 0.6× 11 0.2× 29 0.6× 7 0.2× 41 511
Xue Bai China 15 238 1.7× 63 1.0× 6 0.1× 37 0.7× 11 0.3× 42 570
Yoshifumi Ueda Japan 9 85 0.6× 18 0.3× 14 0.2× 12 0.2× 18 0.4× 10 403
Kenneth Rockwell United States 8 199 1.4× 31 0.5× 20 0.3× 60 1.2× 6 0.1× 13 664
Pei‐Jung Lin Taiwan 13 137 1.0× 17 0.3× 14 0.2× 23 0.4× 5 0.1× 22 433
Kathryn Miranda United States 12 244 1.7× 26 0.4× 14 0.2× 12 0.2× 12 0.3× 22 571

Countries citing papers authored by Fengwen Li

Since Specialization
Citations

This map shows the geographic impact of Fengwen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengwen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengwen Li more than expected).

Fields of papers citing papers by Fengwen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengwen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengwen Li. The network helps show where Fengwen Li may publish in the future.

Co-authorship network of co-authors of Fengwen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Fengwen Li. A scholar is included among the top collaborators of Fengwen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengwen Li. Fengwen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Xinfeng, Jiping Liu, Fengwen Li, et al.. (2021). ATF5, a putative therapeutic target for the mitochondrial DNA 3243A > G mutation-related disease. Cell Death and Disease. 12(7). 701–701. 16 indexed citations
2.
Pan, Jiemin, et al.. (2021). Association of glycemic variability assessed by continuous glucose monitoring with subclinical diabetic polyneuropathy in type 2 diabetes patients. Journal of Diabetes Investigation. 13(2). 328–335. 15 indexed citations
3.
Li, Fengwen, Yinan Zhang, Huizhi Li, et al.. (2020). TIR generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes. Diabetes Research and Clinical Practice. 166. 108289–108289. 43 indexed citations
4.
Zhang, Yinan, Lizhi Zhang, Fengwen Li, et al.. (2020). Relationship Between AST/ALT Ratio and Peripheral Nerve Function in Type 2 Diabetes Mellitus. Nano LIFE. 10(01n02). 2040004–2040004.
5.
Xiong, Ying, Yan Ma, Weirong Fang, et al.. (2019). Protective effects of Clematichinenoside AR against inflammation and cytotoxicity induced by human tumor necrosis factor-α. International Immunopharmacology. 75. 105563–105563. 14 indexed citations
6.
Zhang, Yinan, Jingbin Yan, Fengwen Li, et al.. (2019). De Novo Mutation of m.3243A>G together with m.16093T>C Associated with Atypical Clinical Features in a Pedigree with MIDD Syndrome. Journal of Diabetes Research. 2019. 1–8. 7 indexed citations
7.
Wang, Congrong, Yinan Zhang, Fengwen Li, & Yuehua Wei. (2019). Conserved roles of glucose in suppressing reactive oxygen species-induced cell death and animal survival. Aging. 11(15). 5726–5743. 13 indexed citations
8.
Liu, Zhenzhen, Hua Chen, Qi-Gui Bo, et al.. (2017). Psychological and behavioral characteristics of suicide attempts and non-suicidal self-injury in Chinese adolescents. Journal of Affective Disorders. 226. 287–293. 73 indexed citations
9.
Han, Dan, Weirong Fang, Rui Zhang, et al.. (2015). Clematichinenoside protects blood brain barrier against ischemic stroke superimposed on systemic inflammatory challenges through up-regulating A20. Brain Behavior and Immunity. 51. 56–69. 37 indexed citations
10.
Xiong, Ying, Yan Ma, Han Wang, et al.. (2014). Clematichinenoside AR induces immunosuppression involving Treg cells in Peyer׳s patches of rats with adjuvant induced arthritis. Journal of Ethnopharmacology. 155(2). 1306–1314. 21 indexed citations
11.
Xiong, Ying, Yunman Li, Weirong Fang, et al.. (2012). Anti-arthritic effects of clematichinenoside (AR-6) on PI3K/Akt signaling pathway and TNF-α associated with collagen-induced arthritis. Pharmaceutical Biology. 51(1). 13–22. 41 indexed citations
12.
Cheng, Peng, Pathirage Kamal Perera, Yunman Li, et al.. (2011). Anti-inflammatory effects of Clematis chinensis Osbeck extract(AR-6) may be associated with NF-κB, TNF-α, and COX-2 in collagen-induced arthritis in rat. Rheumatology International. 32(10). 3119–3125. 39 indexed citations
13.
Li, Yunman, et al.. (2009). Mechanism of total saponins of Radix Clematidis on rheumatoid arthritis.. Zhongguo yaoke daxue xuebao. 40(2). 157–160. 1 indexed citations
14.
Li, Fengwen. (2009). Analgesic and anti-inflammatory effect of clematichinenoside. Zhongguo xin yao zazhi. 3 indexed citations
15.
Liu, Lifang, Xiaoli Ma, Yuxin Wang, et al.. (2009). Triterpenoid saponins from the roots ofClematis chinensisOsbeck. Journal of Asian Natural Products Research. 11(5). 389–396. 23 indexed citations
16.
Li, Yunman, et al.. (2009). Effect and mechanism of AR-6 in experimental rheumatoid arthritis. Clinical and Experimental Medicine. 10(2). 113–121. 26 indexed citations
17.
Li, Fengwen. (2006). Study on the effect of Moyu capsule on weight control in rat.. Zhongguo redai yixue. 1 indexed citations
18.
Peng, Zhao, et al.. (2005). Effect of natural taurine on reducing blood lipids. Europe PMC (PubMed Central). 27(1). 70–71. 2 indexed citations
19.
Liu, Xiaoying, Fengwen Li, Lishi Zhang, Hong Liu, & Jinghua Pan. (1998). Effects of H irudo on Vascular Endothelial Dysfunction of Experimental Atherosclerosis in Rabbits. Zhongguo zhongyi jichu yixue zazhi. 4(3). 1 indexed citations
20.
Zhang, Huixiang, et al.. (1990). Separation and Determination of the Volatile Oil of the Parts of the Ginseng Growing on the Ground. Journal of Ginseng Research. 14(2). 87–94. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026